Use of intravitreal anti-VEGF: Retinopathy of prematurity surgeons’ in Hamlet's dilemma.

Simple item page
dc.contributor.authorAzad, Rajvardhan
dc.date.accessioned2012-01-02T06:55:56Z
dc.date.available2012-01-02T06:55:56Z
dc.date.issued2011-11
dc.identifier.citationAzad Rajvardhan. Use of intravitreal anti-VEGF: Retinopathy of prematurity surgeons’ in Hamlet's dilemma. Indian Journal of Ophthalmology. 2011 Nov; 59(6): 421-422.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/136221
dc.language.isoenen_US
dc.source.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214409/en_US
dc.subject.meshAngiogenesis Inhibitors --administration & dosage
dc.subject.meshAngiogenesis Inhibitors --adverse effects
dc.subject.meshHumans
dc.subject.meshInfant, Newborn
dc.subject.meshIntravitreal Injections
dc.subject.meshRetinopathy of Prematurity --drug therapy
dc.subject.meshVascular Endothelial Growth Factor A --antagonists & inhibitors
dc.titleUse of intravitreal anti-VEGF: Retinopathy of prematurity surgeons’ in Hamlet's dilemma.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijo2011v59n6p421.pdf
Size:
333.29 KB
Format:
Adobe Portable Document Format
Description:
Journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Indian Journal of Ophthalmology